In vitro activity of Amphotericin B against zygomycetes isolated from deep mycoses: A comparative study between incubation in aerobic and hyperbaric atmosphere

Medical Mycology

Volumn 50, Issue 4, 2012, Pages 427-432

  Farina, Claudio ^a   Marchesi, Gianmariano ^b   Passera, Marco ^b   Diliberto, Cristina ^c   Russello, Giuseppe ^a   Favalli, Antonio ^c  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c Hyperbaric Center   (Italy)

Author keywords

Chemosensitivity testing; Fungistatic activity; Hyperoxic hyperbaric conditions; Minimal inhibitory concentration; Zygomycetes

Indexed keywords

AMPHOTERICIN B; POSACONAZOLE;

ABSIDIA; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ATMOSPHERE; CONTROLLED STUDY; FUNGUS GROWTH; FUNGUS ISOLATION; HYPERBARIC OXYGEN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUCOR RACEMOSUS; MYCOSIS; NONHUMAN; RHIZOMUCOR PUSILLUS; RHIZOPUS ARRHIZUS; SYNCEPHALASTRUM RACEMOSUM; ZYGOMYCETES;

AEROBIOSIS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ATMOSPHERIC PRESSURE; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIAZOLES; ZYGOMYCOSIS;

FUNGI; ZYGOMYCETES;

EID: 84859767634     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.614964     Document Type: Article

References (24)

1. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. I nfect Dis Clin North Am 2002; 16 : 895-914. (Pubitemid 35477518)
2. Spellberg B, Walsh TJ, Kontoyiannis DP, et al . Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48 : 1743-1751.
3. Duplechain JK, White JA. Mucormycosis of the head and neck. J La State Med Soc 1989; 141 : 9-13.
4. Gordon G, Indeck M, Bross J, e t al . Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988; 28 : 866-867.
5. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980; 90 (Pt1): 737-747. (Pubitemid 10096868)
6. Bentur Y, Shupak A, Ramon Y, e t al . Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 1998; 102 : 822-824. (Pubitemid 28402628)
7. Blaine DA, Frable MA. Mucormycosis. Adjunctive therapy with hydrogen peroxide. Va Med Q 1996; 123 : 30-32.
8. De La Paz MA, Patrinelv JR, Marines HM, e t al . Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 1992; 114 : 208-211.
9. Kajs-Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs 1995; 27 : 174-181.
10. Melero M, Kaimen Maciel I, Tiraboschi N, et al . Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis. Medicina ( B Aires ) 1991; 51 : 53-55.
11. Hamilton JF, Bartkowski HB, Rock JP. Management of CNS mucor mycosis in the pediatric patient. Pediatr Neurosurg 2003; 38 : 212-215. (Pubitemid 36359431)
12. Pelton RW, Peterson EA, Patel BC, e t al . Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Recontr Surg 2001; 17 : 62-66. (Pubitemid 32096614)
13. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25 : 215-229. (Pubitemid 43800540)
14. Segal E, Menhusen MJ, Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. Isr Med Assoc J 2007; 9 : 355-357. (Pubitemid 46839537)
15. Clinical and Laboratory Standard Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi , Approved Standard (2nd ed.), M38-A2. Wayne, PA: Clinical and Laboratory Standard Institute; 2007.
16. Anonymous. Hyperbaric oxygen halts R hizopus infection. J Am Med Assoc 1979; 242 : 314.
17. Ferguson BJ, Mitchell TG, Moon R, e t al . Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988; 10 : 551-559.
18. Newton WD, Cramer FS, Norwood SH. Necrotizing fasciitis from invasive Phycomycetes . Crit Care Med 1987; 15 : 331-332. (Pubitemid 17057705)
19. Pfaller MA, Marco F, Messer SA, et al . In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus , Fusarium , Rhizopus , and other fi lamentous fungi. Diagn Microbiol Infect Dis 1998; 30 : 251-255. (Pubitemid 28210124)
20. Riesselman MH, Hazen KC, Cutler JE. Determination of antifungal MICs by a rapid susceptibility assay. J Clin Microbiol 2000; 38 : 333-340. (Pubitemid 30043312)
21. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005; 11 : 515-517. (Pubitemid 40895150)
22. Bullen JJ, Rogers HJ, Spalding PB, e t al . Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55 (Pt3): 251-258.
23. Barratt DM, Van Meter K, Asmar P, e t al . Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother 2001; 45 : 3601-3602. (Pubitemid 33107886)
24. 2 breathing at 2.0 ATA. J Appl Physiol 1971; 30 : 739-752.